2010
DOI: 10.1021/bi100390z
|View full text |Cite
|
Sign up to set email alerts
|

Crystal Structure of Arginase from Plasmodium falciparum and Implications for l-Arginine Depletion in Malarial Infection,

Abstract: The 2.15 Å resolution crystal structure of arginase from Plasmodium falciparum, the parasite that causes cerebral malaria, is reported in complex with the boronic acid inhibitor 2(S)-amino-6-boronohexanoic acid (ABH; Kd = 11 μM). This is the first crystal structure of a parasitic arginase. Various protein constructs were explored to identify an optimally active enzyme form for inhibition and structural studies, and to probe the structure and function of two polypeptide insertions unique to malarial arginase: a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
51
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
8
1
1

Relationship

3
7

Authors

Journals

citations
Cited by 41 publications
(52 citation statements)
references
References 59 publications
1
51
0
Order By: Relevance
“…falciparum and P. berghei ANKA both express a functional arginase enzyme that produces ornithine from arginine in vitro [7,19]. To determine whether parasite-expressed arginase is required for arginine depletion in vivo, we analyzed plasma amino acids from C57BL/6 mice infected with argKO or WT parasites.…”
Section: Evaluation Of Parasite Arginase Level As a Possible Cause Ofmentioning
confidence: 99%
“…falciparum and P. berghei ANKA both express a functional arginase enzyme that produces ornithine from arginine in vitro [7,19]. To determine whether parasite-expressed arginase is required for arginine depletion in vivo, we analyzed plasma amino acids from C57BL/6 mice infected with argKO or WT parasites.…”
Section: Evaluation Of Parasite Arginase Level As a Possible Cause Ofmentioning
confidence: 99%
“…Interestingly, the corresponding residue is similarly nonpolar in two other parasitic arginases: P228 in Plasmodium falciparum arginase 58 and V149 in Leishmania mexicana arginase. 54 Differences in polarity and size at this position in parasitic arginases compared with human arginases may be a contributing factor to the alternative binding modes of α,α-disubstituted amino acid inhibitors.…”
Section: Resultsmentioning
confidence: 99%
“…Phosphopantothenoyl cysteine decarboxylase (XP_001349363.1) is an enzyme that has no homologs in humans and is one of the enzymes to be considered as a drug target (Plata et al, 2010). The inhibition of the enzymatic activity of arginase (XP_001351939.1) showed reduced liver infectivity in vivo and therefore arginase could be a drug candidate for antimalarial therapy with the availability of its protein structure (Dowling et al, 2010). Rhoptry associated proteins (XP_001352164.1) RAP-1 and RAP-2 are recommended as vaccine candidates for asexual blood-stage due to their low polymorphism in global population (Garzon-Ospina et al, 2010).…”
Section: Annotation Transfer By Homologymentioning
confidence: 99%